BG105430A - Compositions and methods for the supply of powder active substance in the lungs - Google Patents

Compositions and methods for the supply of powder active substance in the lungs

Info

Publication number
BG105430A
BG105430A BG105430A BG10543001A BG105430A BG 105430 A BG105430 A BG 105430A BG 105430 A BG105430 A BG 105430A BG 10543001 A BG10543001 A BG 10543001A BG 105430 A BG105430 A BG 105430A
Authority
BG
Bulgaria
Prior art keywords
lungs
compositions
supply
methods
active substance
Prior art date
Application number
BG105430A
Other languages
Bulgarian (bg)
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of BG105430A publication Critical patent/BG105430A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

The active agent formulation is in dry powder form and exhibits: (i) low moisture sorption, and (ii) resistance to a hygroscopic growth, particularly under simulated lung conditions. 23 claims, 5 figures
BG105430A 1998-09-14 2001-04-10 Compositions and methods for the supply of powder active substance in the lungs BG105430A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
BG105430A true BG105430A (en) 2001-12-29

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105430A BG105430A (en) 1998-09-14 2001-04-10 Compositions and methods for the supply of powder active substance in the lungs

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198593C (en) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CN1671643B (en) 2002-02-25 2013-05-29 扩散药品有限公司 Bipolar trans carotenoid salts and their uses
WO2004004798A2 (en) * 2002-07-03 2004-01-15 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
MXPA05006802A (en) * 2002-12-19 2005-09-08 Pharmacia Corp Non-hygroscopic formulation comprising a hydroscopic drug.
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
MXPA06012240A (en) 2004-04-23 2007-01-31 Cydex Inc Dpi formulation containing sulfoalkyl ether cyclodextrin.
EP2540696B1 (en) * 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
KR20070110418A (en) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 Particle and preparation containing the particle
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
MX348982B (en) 2005-10-26 2017-07-06 Cydex Pharmaceuticals Inc Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof.
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
US20100093875A1 (en) * 2006-10-25 2010-04-15 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EP3483140A1 (en) 2007-04-13 2019-05-15 Diffusion Pharmaceuticals LLC Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
CN101878040A (en) 2007-10-31 2010-11-03 扩散药品有限公司 A new class of therapeutics that enhance small molecule diffusion
US9610343B2 (en) * 2009-05-20 2017-04-04 Aeras Global Tb Vaccine Foundation Stable, spray dryed, immunogenic, viral compositions
CN108464976A (en) 2009-06-22 2018-08-31 扩散药品有限公司 Diffusion promotes compound and its independent or application together with Thrombolytic Drugs
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
JP6349304B2 (en) 2012-05-03 2018-06-27 ヤンセン・サイエンシズ・アイルランド・ユーシー Polyinosine-polycytidylic acid (poly (I: C)) formulation for the treatment of upper respiratory tract infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
KR102489034B1 (en) 2016-03-24 2023-01-13 디퓨젼 파마슈티컬즈 엘엘씨 Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
WO1993025198A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
NZ510168A (en) 2003-09-26
WO2000015262A1 (en) 2000-03-23
EA003476B1 (en) 2003-06-26
LV12658A (en) 2001-05-20
IL141562A (en) 2007-07-24
EA200100300A1 (en) 2001-10-22
AP1374A (en) 2005-02-28
KR20010075063A (en) 2001-08-09
TNSN99173A1 (en) 2005-11-10
ID28845A (en) 2001-07-05
OA11781A (en) 2005-07-26
HK1042231A1 (en) 2002-08-09
TR200101182T2 (en) 2001-09-21
AR022090A1 (en) 2002-09-04
UA76085C2 (en) 2006-07-17
EE200100151A (en) 2002-06-17
AP2001002093A0 (en) 2001-03-31
SK3442001A3 (en) 2001-11-06
BR9913722A (en) 2001-05-29
HN1999000159A (en) 1999-11-11
CZ2001829A3 (en) 2001-09-12
HRP20010189A2 (en) 2005-04-30
MY129282A (en) 2007-03-30
YU24201A (en) 2003-08-29
EP1117442A1 (en) 2001-07-25
DZ2892A1 (en) 2003-12-15
GEP20043257B (en) 2004-06-25
CA2343920A1 (en) 2000-03-23
AU753014B2 (en) 2002-10-03
IL141562A0 (en) 2002-03-10
PL346768A1 (en) 2002-02-25
TWI226248B (en) 2005-01-11
LT4897B (en) 2002-02-25
PE20001061A1 (en) 2000-10-08
PL195574B1 (en) 2007-10-31
LV12658B (en) 2001-09-20
MA25590A1 (en) 2002-12-31
AU6039799A (en) 2000-04-03
CN1317977A (en) 2001-10-17
NO20011251D0 (en) 2001-03-13
GT199900156A (en) 2001-03-07
CO5130023A1 (en) 2002-02-27
ZA200101995B (en) 2002-03-11
SA99200718B1 (en) 2006-11-04
PA8481901A1 (en) 2002-04-25
LT2001021A (en) 2001-11-26
HUP0103837A3 (en) 2002-11-28
IS5878A (en) 2001-03-05
UY25711A1 (en) 1999-11-17
HUP0103837A2 (en) 2002-05-29
JP2002524535A (en) 2002-08-06
NO20011251L (en) 2001-04-17

Similar Documents

Publication Publication Date Title
BG105430A (en) Compositions and methods for the supply of powder active substance in the lungs
IS5108A (en) New inhalation formulation in bulk with a mass of 0.28 to 0.38 g / ml, method of preparation and use of the preparation
ATE382386T1 (en) MULTIDOSIS DRY POWDER INHALER WITH POWDER RESERVOIR
HU9201521D0 (en) Stimulating unit containing nicotine
EE04794B1 (en) Chewing gum, a method for preparing a chewing gum composition and using a natural herbal component to coat the chewing gum
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
PT877602E (en) PROCESS FOR THE MANUFACTURE OF PULMONARY SURFACTANT COMPOSITIONS IN PO
EP0156924A4 (en) Chemically active composition containing ferrous ion.
IS5109A (en) New inhalation formulation in bulk with a mass of 0.28 to 0.38 g / ml containing formoterol
IT1247945B (en) AGENT HAVING BACTERIOSTATIC AND BACTERICIDAL ACTIVITY
HU9403617D0 (en) Dry flowable agricultural compositions of glyphosate
EP0792653A3 (en) Solid polysaccharide materials for use as wound dressings
HUT77000A (en) Substituted pyrazine derivatives, preparation and use thereof, and herbicide compositions containing these compounds as active ingredients
ZA973751B (en) Pesticides comprising benzophenanthridine alkaloids.
EP0212837A3 (en) Deodorizing agent
TW325393B (en) Methods of making a dry, flowable powder of acifluorfen and a composition prepared therefrom
EP0286601A3 (en) Powdered deodorant composition for shoes, in particular for sporting shoes
EP0337212A3 (en) Silicia gels for controlling insect pests
ATE341346T1 (en) SPRAY WITH AMPHOTERIC COMPOSITION TO REDUCE ODORS
IL57058A (en) Dichlorobenzodioxole derivatives,their preparation and their use as synergistic agents in insecticidal and acaricidal compositions
SE8300495D0 (en) IMPROVEMENTS IN OR RELATING TO NASAL PHARMACEUTICAL COMPOSITIONS
JPS5742617A (en) Flexible cataplasma
JPS5699766A (en) Preparation of modified starch
AR224932A1 (en) HERBICIDE COMPOSITIONS CONTAINING 3-AMINO-TRIAZOL CHLORHYDRATE AS AN ACTIVE AGENT, ALONE OR IN MIXTURE WITH SOLUBLE THIOCIANATES AND PROCEDURES FOR PREPARING THEM
MX9707902A (en) Flavorful zinc compositions for oral use incorporating copper.